Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, dose-ranging, placebo-controlled study
收藏Mendeley Data2026-04-18 收录
官方服务：
资源简介：
Supplementary appendix for an article "Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, dose-ranging, placebo-controlled study" for The Journal of the American Academy of Dermatology
创建时间：
2023-10-13
